Leap as a global healthcare corporation

2018

• 03
  Selected as a “High-Growth Company in the Asia-Pacific region” by the United Kingdom’s Financial Times
• 03
  Took over the management rights of Next BT

2017

• 02
  DMD medicine [BLS-M22] designated as an orphan drug by United States’ FDA (ODD)

Accelerate growth

2017

• 12
  Received the “Grand Prize” in the R&D category at the 2017 Korea SME Awards / Institute for Industrial Policy Studies
• 12
  Selected as an “outstanding company R&D center” in the second half of 2017 / Ministry of Science & ICT
• 10
  Launched the “She’s Ready”, a skincare brand
• 09
  Relocated and installed a production line from Daejeon to National Food Cluster in Iksan, Jeollabuk-do
• 08
  Started Clinical Phase 2b of the treatment vaccine for cervical cancer [BLS-M07]
• 07
  Obtained the hygiene license from the China Food and Drug Administration (CFDA) for its cosmetics products, "Doctors PGA Moisture Mask Pack"
• 07
  Signed for the "joint development of the next-generation of female cancer treatment vaccines" with CHA Bundang Medical Center
• 06
  Completed a non-clinical toxicity test of DMD medicine [BLS-M22]
• 01
  Signed an agreement for vaccine development with CHA Vaccine Institute

2016

• 12
  Received the “Excellence Prize” at the 13th Korea New Growth Management Awards / Ministry of Trade, Industry and Energy
• 10
  Selected as a K-Brain Power company of 2016 / Institute for Industrial Policy Studies
• 09
  Merged and relocated Suji Headquarters, Gyeonggi-do
• 07
  Listed on KOSDAQ

Prepare foundation for growth

2016

• 12
  Completed Clinical Phase 2b of CIN1 medicine [BLS-H01]
• 11
  Clinical Phase 1 of CIN1 medicine [BLS-H01] approved (Ministry of Food and Drug Safety)
• 11
  Listed on KONEX
• 11
  Completed Clinical Phase 2a of the treatment vaccine for cervical cancer [BLS-M07]

Secure R&D competitiveness

2008

• 07
  Established Japan Office (Osaka)

2007

• 12
  Selected as one of Korea's Top 10 New Technologies and received the Technology Award for <Mass-production Manufacturing Technology for Poly-γ-glutamic Acid with Extremely High Molecular Weight> / Ministry of Trade,Industry and Energy
• 08
  Acquired "NET", a new technology certification <Medicine Material Development Technology Using HighMolecular Weight Poly-γ-glutamic Acid> / Korea Industrial Technology Association

Establish business foundation

2005

• 12
  Attracted investment from and signed a joint technology development contract with Green Cross Corp.

2001

• 08
  Selected as an INNO-BIZ (Grade Aa) / Ministry of SMEs and Startups

2000

• 07
  Recognized as a company affiliate research center / Korea Industrial Technology Association
• 01
  Founded BioLeaders Co., Ltd.